a genome engineering company of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers
Industry Biotechnology
A.I.dvisor indicates that over the last year, CLLS has been loosely correlated with SLN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CLLS jumps, then SLN could also see price increases.
Ticker / NAME | Correlation To CLLS | 1D Price Change % | ||
---|---|---|---|---|
CLLS | 100% | -5.83% | ||
SLN - CLLS | 40% Loosely correlated | +0.42% | ||
TGTX - CLLS | 36% Loosely correlated | -3.75% | ||
NUVB - CLLS | 31% Poorly correlated | -7.45% | ||
DTIL - CLLS | 31% Poorly correlated | -4.41% | ||
PMVP - CLLS | 30% Poorly correlated | +0.64% | ||
More |
Ticker / NAME | Correlation To CLLS | 1D Price Change % |
---|---|---|
CLLS | 100% | -5.83% |
cells theme (4 stocks) | 37% Loosely correlated | +0.92% |
gene-based medicines theme (3 stocks) | 32% Poorly correlated | +0.40% |
europe theme (180 stocks) | 29% Poorly correlated | +0.17% |
drugs theme (265 stocks) | 19% Poorly correlated | +5.37% |
pharmaceuticals theme (167 stocks) | 18% Poorly correlated | +0.82% |
More |